<DOC>
	<DOCNO>NCT01705522</DOCNO>
	<brief_summary>The investigator intend assess role several biomarkers prediction relapse IBD . Clinical , laboratory endoscopic data gather predictive score derive order ass relapse risk 1 year .</brief_summary>
	<brief_title>Multimodal Approach IBD Patients</brief_title>
	<detailed_description>Patients confirm diagnosis IBD prospectively assess yearly basis order ass relapse risk factor . Disease activity assess use Mayo score UC patient CDAI Crohn 's disease endoscopic activity assess use Mayo endoscopic subscore UC patient Simple Endoscopic Score Crohn 's Disease CD patient . Serum fecal biomarkers obtainted study visit ( C-reactive protein , fecal calprotectin ) . Data current past medication IBD also gather .</detailed_description>
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Liver Diseases</mesh_term>
	<mesh_term>Colitis , Ulcerative</mesh_term>
	<mesh_term>Crohn Disease</mesh_term>
	<mesh_term>Colitis</mesh_term>
	<mesh_term>Fatty Liver</mesh_term>
	<mesh_term>Vitamin D Deficiency</mesh_term>
	<mesh_term>Non-alcoholic Fatty Liver Disease</mesh_term>
	<criteria>ulcerative colitis Crohn 's disease age 18 clinical remission sign informed consent pregnant woman refusal sign inform consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>IBD</keyword>
	<keyword>ulcerative colitis</keyword>
	<keyword>Crohn 's disease</keyword>
	<keyword>NAFLD</keyword>
	<keyword>biomarkers</keyword>
	<keyword>vitamin D</keyword>
</DOC>